Internal Medicine, Pulmonary Disease · Bryn Mawr, PA
NPI
1841493285
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
825 Old Lancaster Rd, Suite 320
Bryn Mawr, PA, 19010
Phone (610) 527-3800
Groups this clinician bills Medicare through
Medicare paid, 2024
$199K
1,744 services
Medicare patients, 2024
656
Average age 74
Drug cost, 2024
$765K
1,105 prescriptions
Company payments, 2025
$2,189
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Catherine A Riley was code 99215 (office e&m - established), 419 times for 243 patients. In total Catherine A Riley billed 1,744 services in 29 codes, and Medicare paid $199K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 419 | 243 | $139.29 | $58K |
| 99291 Critical Care E&M | Facility | 407 | 46 | $170.48 | $69K |
| 99214 Office E&M - Established | Office | 209 | 148 | $94.41 | $20K |
| 99233 Hospital E&M - Subsequent | Facility | 177 | 33 | $94.82 | $17K |
| 95810 Sleep Study | Facility | 97 | 96 | $92.42 | $8,965 |
| 99204 Office E&M - New | Office | 51 | 51 | $117.54 | $5,995 |
| 95806 Sleep Study | Office | 51 | 49 | $71.88 | $3,666 |
| 94729 Pulmonary Function Testing | Facility | 37 | 37 | $6.83 | $253 |
| 94060 Pulmonary Function Testing | Facility | 35 | 35 | $7.85 | $275 |
| 95811 Sleep Study | Facility | 31 | 29 | $97.46 | $3,021 |
| 94726 Pulmonary Function Testing | Facility | 28 | 28 | $9.09 | $255 |
| 99205 Office E&M - New | Office | 27 | 27 | $170.86 | $4,613 |
| 94729 Pulmonary Function Testing | Office | 25 | 25 | $43.07 | $1,077 |
| 94060 Pulmonary Function Testing | Office | 24 | 24 | $29.31 | $704 |
| 94727 Pulmonary Function Testing | Office | 24 | 24 | $34.58 | $830 |
By year: 2022 $205K for 1,979 services; 2023 $203K for 1,884 services; 2024 $199K for 1,744 services.
Medicare prescription drug claims, 2024
In 2024, the drug Catherine A Riley prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 168 prescriptions and refills. In total Catherine A Riley wrote 1,105 Medicare prescriptions that cost $765K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 168 | 250 | 37 | $157K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 113 | 144 | 43 | $2,814 |
| Fluticasone Propionate Generic | 92 | 180 | 33 | $1,298 |
| Breo Ellipta Fluticasone/Vilanterol | 80 | 88 | 16 | $34K |
| Ropinirole Hcl Generic | 70 | 130 | 15 | $1,027 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 61 | 69 | 12 | $4,262 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 51 | 56 | 12 | $33K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 41 | 51 | Under 11 | $24K |
| Montelukast Sodium Generic | 37 | 85 | Under 11 | $322 |
| Prednisone Generic | 33 | 33 | 25 | $126 |
| Symbicort Budesonide/Formoterol Fumarate | 32 | 46 | Under 11 | $9,319 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 29 | 45 | Under 11 | $21K |
| Famotidine Generic | 29 | 65 | Under 11 | $105 |
| Incruse Ellipta Umeclidinium Bromide | 26 | 34 | Under 11 | $11K |
| Spiriva Respimat Tiotropium Bromide | 24 | 40 | Under 11 | $20K |
Brand drugs: 627 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Catherine A Riley $2,189 ($2,189 in general payments such as food, travel and fees) from 26 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $252.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 12 | $252 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $242 |
| Grifols USA, LLC | 5 | $152 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $150 |
| Pulmonx Corporation LUNG | 2 | $149 |
| Abbvie Inc. ABBV | 4 | $144 |
| Harmony Biosciences LLC HRMY | 3 | $132 |
| Viatris Specialty LLC | 5 | $131 |
| GlaxoSmithKline, LLC. GSK | 5 | $108 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $99.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.